Bristol-Myers Squibb Company
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
47,512.73 |
46,967.61 |
43,362.20 |
42,679.59 |
39,499.69 |
37,325.70 |
Przychód Δ r/r |
0.00% |
-1.15% |
-7.68% |
-1.57% |
-7.45% |
-5.50% |
Przychód (min) |
47,412.78 |
46,278.10 |
41,438.65 |
42,555.99 |
38,437.46 |
36,321.93 |
Przychód (max) |
47,822.55 |
48,488.58 |
45,493.40 |
42,803.19 |
40,677.96 |
38,439.12 |
EBITDA (średnia) |
13,892.17 |
13,732.78 |
12,678.60 |
12,479.02 |
11,549.25 |
10,913.60 |
EBIT (średnia) |
3,318.23 |
3,280.16 |
3,028.37 |
2,980.69 |
2,758.61 |
2,606.78 |
EBIT % |
6.98% |
6.98% |
6.98% |
6.98% |
6.98% |
6.98% |
Zysk netto (średni) |
1,915.69 |
13,094.06 |
11,893.76 |
9,385.83 |
11,475.50 |
10,771.84 |
Zysk netto % |
4.03% |
27.88% |
27.43% |
21.99% |
29.05% |
28.86% |
EPS (średnia) |
0.92 |
6.46 |
6.01 |
5.83 |
5.66 |
5.31 |
Liczba analityków (Przychody) |
19 |
16 |
25 |
22 |
10 |
15 |
Liczba analityków (EPS) |
16 |
17 |
17 |
9 |
4 |
3 |
symbol |
BMY |
BMY |
BMY |
BMY |
BMY |
BMY |